Home AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods
 

Keywords :   


AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods

2014-11-13 19:01:24| Biotech - Topix.net

Isis Pharmaceuticals and AstraZeneca today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides. The new delivery approaches seek to target the desired tissue more effectively.

Tags: methods delivery targeted pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
24.11NU: EYE
24.11
More »